30 Oct

HealthBeacon Appoints CFO

Irish Digital Health Company Expands Team:  Leading Digital Health Company HealthBeacon, with the world’s first digital Injection Care Management System that drives adherence to therapy for patients on self-administered injectable medications, is delighted to announce the appointment of its new Chief Financial Officer Laurence Flavin to their growing global team. October 2020.

Headquartered in Dublin with additional offices in Boston and Montreal, the company is at a key growth inflection point having secured significant contracts with over 14 major pharmaceuticals, insurance and specialty pharmacies across the globe and implementing its ICMS technology, anchored by its FDA cleared smart sharps bin, in 2020.

Highly experienced CFO and company builder, Laurence Flavin most recently helped build Finance Ireland into Ireland’s largest non-bank lender, raising over €1bn in equity and debt facilities. A qualified chartered accountant, Laurence has a broad base of experience working in capital markets, taking a company public across Dublin and London, and managing corporate transactions.

Commenting on the appointment, Jim Joyce, CEO and Co-Founder, said “Laurence is a talented, driven, financial business leader with a proven reputation of building quality and high growth organisations. His experience in fund raising, scaling companies and working in a highly regulated sector makes him a great fit for HealthBeacon and we are delighted to have him on the team.”

 

HealthBeacon

HealthBeacon’s vision to build smart tools for managing medications saw the launch of the world’s first truly digital enabled Injection Care Management System (ICMS) for the tens of millions of patients taking injectable medications at home. Patients on chronic treatments require digital, virtual and remote support to ensure taking treatment as prescribed and engaging with their condition. Medical Adherence studies have documented that approx. 50% of patients fail on prescribed chronic medications in the first year of treatment, while HealthBeacon’s technology, increases the number of patients that will ultimately succeed on their treatment.

 

Future Health

2020 is witnessing the world’s rapid adoption of digital, virtual and remote healthcare delivery for which HealthBeacon is at the forefront, having developed a leading technology platform for patients on chronic injectable treatment, a market projected to be worth over $300 billion by 2024.

In 2019 HealthBeacon completed a €12m Series A investment round and are in the process of completing an additional financing of between €3-5m anticipated to close in 2020. Investors in HealthBeacon include Enterprise Ireland, Oyster Capital, Cantor Fitzgerald, BVP, Elkstone Partners, Singapore’s SGInnovate and US-based Manatt.

 

For further information contact: Emer O’Reilly, ORPR, T: +353868593658 E: emer@orpr.ie

 

 

About HealthBeacon

HealthBeacon a medication adherence technology company, has developed the World’s first Injection Care Management System for patients that self-administer injectable medication in their homes. HealthBeacon eases the burden of managing patients’ injectable medications from home through their FDA cleared Smart Sharps Bin Technology. With the intervention of HealthBeacon’s Injection Care Management System, patients’ persistence and adherence to medication is increased by 25-30% within twelve months of initiating therapy.  The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow.  This technology has been adopted across thirteen countries with >420,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%.

For more information or to contact HealthBeacon, visit www.healthbeacon.com or engage with @HealthBeacon on LinkedIn & Twitter.

10 Sep

Virtual Injection Training: A Novel Addition to HealthBeacon’s Injection Care Management System

Virtual Injection Training study represents new approach to successful patient onboarding. September 2020.

Here at HealthBeacon we are continuously looking for novel approaches to successful onboarding of patients into our Injection Care Management System (ICMS™). Research into video assisted injection training for patients by Sean Glynn, Director of Health Economics and Outcomes Research, explores this idea further. Reviewed by Dr.Sharifah Sarhan, Medical Science Liaison and our experienced nurse trainer, Lorraine Smith, this innovative idea has potential to become a key aspect of our ICMS™ offering.

Encouraging patient autonomy and supporting them to self-manage medication regimes at home is central to the ethos of HealthBeacon and our ICMS™. As healthcare and the management of medical conditions becomes increasingly digital, the need for remote patient care is coming to the fore. This is especially so in the current era of COVID-19. To explore how we can further support such remote care, HealthBeacon conducted a study to assess the efficacy of remote injection training as an exciting alternative to in-person training for patients. Our experienced nurse trainer, Lorraine Smith also offers her opinion on this innovative offering and what it could mean for both patients and practitioners alike – Dr.Sharifah Sarhan, MSL, HealthBeacon

Virtual Injection Training Study

by Sean Glynn, Director of HEOR, HealthBeacon

 

In-home injection training is the current standard of care for patients newly prescribed a self-injectable medication. This service may be provided through a pharmaceutical company’s patient support program as an aid to successful initiation to therapy. Patients may also get this training in clinic depending on the requirements of the product. However, both training modes create financial and resource burdens on healthcare systems and/or directly on the patient. (Homer, 2009)

Previous research has shown that video-based self-injection training may be a more desirable option for patients than in-person training, and that it can result in high levels of confidence amongst patients to perform the self-injection correctly (Homer, 2019). Video training, was found to reduce nurse resource utilization, while demonstrating equal efficacy when compared to in-person training (Katz, 2015).

As a digital health company, HealthBeacon has developed an Injection Care Management System™ to support patients on self-injectable medications. As such, through leveraging e-learning and tele-health concepts, a training auto-injector to simulate the injecting experience, and a novel approach, HealthBeacon sought to improve the patient training system and demonstrate that Virtual Injection Training is as viable and as effective an approach as in-person training.

Prior to deployment of this new platform, HealthBeacon wanted to ensure that trainees would receive the same high-quality training as they would from a nurse practitioner, whilst ensuring patients’ safety and confidence in performing the self-injection. Our paper summarizes HealthBeacon’s first round assessment of the program.

 

To receive a full copy of our Virtual Injection Training White Paper and to learn more about our study, please email: Sharifah.sarhan@healthbeacon.com or sean@healthbeacon.com

 

Results

Our research provided exciting results: virtual injection training can be deployed with as high and equal quality as in-person training. Overall knowledge regarding self-injection was higher in the virtual-injection group, with participants in both groups having equal and high scores regarding their confidence to self-inject remotely.

Resource utilization and associated costs were also considered as part of this study. Analysis of cost for both training modes show that the VIT can be performed for 50%-60% of the IPT cost, resulting in considerable cost savings.

These results represent an exciting idea that remote patient interactions and training is not only possible, but equitable to in-person interactions. As the future of medicine becomes increasingly digital, the need for such service offerings in remote patient management systems will only increase.

We reviewed these findings with our nurse Lorraine Smith, (R.G.N. BSc with over 20 years nursing experience, 10 of those specifically in-home injection education and training) who said, “These results give me confidence as a trainer that conducting the training remotely can be done effectively. This training is a critical first step for patients, to give them the experience needed to build their confidence.”

 

Q&A with Nurse Lorraine

In discussion with our experienced nurse trainer, Lorraine Smith, Dr. Sharifah Sarhan asked for her opinions and thoughts on virtual injection training as a novel alternative to in-person training. Lorraine has over 20 years’ experience as a nurse and a decade of experience training patients on self-injecting at home and offers some invaluable insights.

From your experience training patients how to self-inject, what are some of the things you must consider prior to training?


For me, when training patients how to self-inject, the key thing to think about is the pre-training interaction. Both the patient and their healthcare practitioners (HCPs) need to know they are in good hands. Reassurance is key. With virtual injection training, we also want to reassure them both that we have put time and effort into getting demo devices to patients to practice with and provide them with the equipment they need to practice successfully before attempting to self-inject.

What do you think are some of the benefits of virtual injection training for patients?

Of course, HCPs are indispensable, but virtual injection training can give patients great insight and further understanding into how to use their injection device, providing them with greater autonomy over their medication management, and increasing their compliance and overall wellbeing. Although virtual, patients are still linked-in with their HCPs and can rest-assured that they are supported by them.

Virtual training will also free up time for busy HCP’s in the hospital / clinic environment. It allows faster scheduling of patient training than in person training provides (nurses can be booked up, patients can live far away in hard to access areas leading to scheduling delays, etc). Also, should training not happen for any reason, be delayed or was not satisfactory, HealthBeacon are open and honest in their ICMS™ service, giving feedback as required and are someone prescribers can trust. Experienced RGN’s are interacting with patients and will relay any issues they identify.

In the unlikely event we are concerned that a patient may need a supervised visit, we let them know this and do not assume the patient will eventually ‘get around to it’ or get over any fears they may have regarding self-injecting, for example. We follow up with our referred patients to ensure patients have the level of support they need.

How do you feel virtual injection training could change your practice going forward?

From my more recent experience of visiting patients at home, I have noticed a recurring worry. Patients are very concerned that HCP’s coming into their home could potentially expose them to COVID -19. Given the challenges facing us all currently, the need for an alternative to in-patient interactions is significant. The option of a virtual interaction as part of the ICMS™, with an experienced nurse in a remote, and safe manner, who can guide patients on their self-injection journey, can only benefit everyone.

 

 

Sean Glynn, Director of HEOR, joined the HealthBeacon team three years ago with the critical role of launching HealthBeacon’s operations in the US. Sean’s background in behavioral sciences and his deep understanding of the medication adherence issue will be instrumental in furthering HealthBeacon’s mission to improve patient outcomes. Sean is based out of HealthBeacon’s Boston office.

 

 

 

 

Dr.Sharifah Sarhan joined the HealthBeacon team as a Medical Science Liaison, to facilitate clinical research and assist with Regulatory Affairs. Sharifah is a medical doctor, graduating from University College Dublin and experience across a number of medical specialities as a junior doctor. Sharifah is based out of HealthBeacon’s office in Dublin, Ireland.

 

 

 

 

 

Lorraine Smith, R.G.N. BSc, has over 20 years’ experience working as nurse in a variety of hospitals in Ireland. Lorraine also has 10 years’ experience working specifically in the area of patient education and self-injection training in the home setting.

 

 

 

 

 

About HealthBeacon

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication at home. HealthBeacon’s FDA cleared smart sharps bin tracks patient injection history, provides personalized interactive reminders and safely stores used injectables. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy. The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow. This technology has been adopted across thirteen countries with >300,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%.

 

References

• Homer D. (2019). Using video-based training for button-free auto-injection of subcutaneous methotrexate: A pilot study. Musculoskeletal Care, 17(3), 247–279. https://doi.org/10.1002/msc.1420
• Homer D, Nightingale P, &Jobanputra, P. (2009). Providing patients with information about disease‐modifying anti‐rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction. Musculoskeletal Care, 7(2), 78–92. https://doi.org/10.1002/msc.141
• Katz SJ, Leung S. (2015). Teaching methotrexate self-injection with a web-based video maintains patient care while reducing healthcare resources: a pilot study. Rheumatology International, 35(1):93-96. https://doi.org/10.1007/s00296-014-3076-1

03 Sep

Medics Need Apply: The Increasing Role of Doctors outside the Clinical World

HealthBeacon appoints new Medical Science Liaison. August 2020.

HealthBeacon is happy to announce the latest addition to our expanding team, Dr. Sharifah Sarhan, as our new Medical Science Liaison. Having experience across several medical specialities as a junior doctor, Sharifah joins HealthBeacon in our Dublin Headquarters to facilitate research, assist in regulatory affairs and to help bring clinical experience and skills into the non-clinical world.

Hospitals and Clinics are full of smart and compassionate Doctors and the field of Digital Health needs them. Sometimes we need them to adopt, embrace and improve new technologies, but sometimes we need them as team members, working inside a Digital Health company, and outside of clinical medicine. We find the collaboration between technologists and doctors to be always insightful and often truly transformational in how we develop our products and services for patients. – Jim Joyce, CEO HealthBeacon

 

Sharifah shares her thoughts with us on how she sees doctors playing an increasing role in non-clinical medicine and in the world of digital health.

I sometimes draw comparisons between my experience in clinical medicine and that of being on a treadmill; the path is set out in front of you, all you must do is take the next step. Of course, a considerable amount of hard work, long hours, study and sacrifice go into those steps, but the path is there for you to walk, nonetheless. Graduating from university, the course of your career is for the most part at your footsteps, from junior doctor, to basic and higher training, with exams in between, the path is clear if not long. The longer you are on that treadmill however, and the faster it gets, the thought of stepping off becomes more daunting. To take what can feel like a giant leap, to follow a different path or perhaps create your own, can be overwhelming and can understandably leave many doctors, including myself, feeling as though they are programmed only to walk that treadmill. Clinical medicine is a fantastic and hugely rewarding career, and one in which you can make a tangible difference to the lives of others, but it is not the only path a doctor can take. Opportunities to create change, to improve the care we give, enhance patient outcomes, while continuing professional development, are not only found in the clinical world.

As healthcare must change and adapt to overcome the challenges it faces, so too must the role of a doctor. Increasingly, doctors are becoming more involved in non-clinical aspects of healthcare, whether it be in pharmaceuticals, research, medical education and writing or in executive and management positions. As physicians, we endeavour to enhance patient outcomes in the most acceptable and efficient way we can. Such aspirations can now be realised outside of the clinical environment. Problem solving, communication, organisational and triage skills are not only of use within hospital and clinic walls. The opportunities to transfer these skills, learned in medical school and honed through clinical practice, to other areas of healthcare are numerous and far-reaching. One such area is that of the ever-expanding field of Digital Health.

As one of the most exciting and promising areas of non-clinical medicine, Digital Health has huge potential to alter medical practice as we know it and change patient health behaviours. When we consider some of the advances in healthcare technology that exist today, whether it be robot assisted surgery, subdermal devices that can detect and prevent seizure activity in the brain, mobile applications that detect skin cancer, or simple vital sign monitoring devices we wear on our wrists as we go about our day, we can appreciate how digital health is becoming part of the meshwork of both modern medicine and modern life. Indeed, as the challenges of an aging population and increased disease burden escalate, with the corresponding strain on resources and finances, so too does the need to meet these challenges. Now more than ever, in this COVID-era, the idea remote patient monitoring is not only an interesting area of development, but an imperative one. The recent pandemic has highlighted both its need, and its scope.

Video consultations and virtual clinic appointments have made it possible for practitioners to stay connected with patients, continue to deliver high-quality real-time care and support, precise and customised to each patient, while ensuring the safety of both patients and doctors. Furthermore, these difficult times have taught us that as a community, we possess the ability to take the management of disease into our own hands. Whether it be socially distancing and wearing PPE to try and control one of the most significant pandemics in history or adhering to medication regimes to maintain control over chronic illness, we have the power to change the course of our own health. Central to this, are the tools and the technologies that give us such power.

HealthBeacon’s premise is simple, but precise. Ultimately, it provides patients with greater autonomy over their illness, while giving physicians the insights needed to deliver more optimal and efficient care. As such, I am delighted to be working as part of the HealthBeacon team in advancing patient care in Ireland and internationally. Although I will always enjoy aspects of clinical medicine and can appreciate it as a unique and truly humbling profession, I am looking forward to exploring new opportunities in an exciting, non-clinical career in Digital Health, off the treadmill.

HealthBeacon is proud to acknowledge the skills doctors can have both in the clinical and the digital world, and is excited to have Sharifah as part of our team helping to drive the research, data and innovation behind the care we provide.

 

          

Jim Joyce, CEO of HealthBeacon, has an MBA from University College of Dublin and BA in Economics from Fordham  University. He is the CEO and Co-Founder of HealthBeacon, a Dublin, Ireland based medical adherence technology company.

                   

 

   

           

 

Dr.Sharifah Sarhan, MB BAO BCh has joined the HealthBeacon team as a Medical Science Liaison, to facilitate clinical research and assist with Regulatory Affairs. Sharifah is a medical doctor, graduating from University College Dublin and experience across several medical specialities as a junior doctor. Sharifah is based in HealthBeacon’s office in Dublin, Ireland.

 

 

About HealthBeacon

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication at home. HealthBeacon’s FDA cleared smart sharps bin tracks patient injection history, provides personalized interactive reminders and safely stores used injectables. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy. The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow. This technology has been adopted across thirteen countries with >300,000 injections tracked since launch in 2014, with a patient acceptance rate of
80-90%.

04 Aug

HEALTHBEACON SECURES OFFICIAL NHS SUPPLIER APPOINTMENT

Crown Commercial Service Supplier Logo - HealthBeaconDigital Health Company To Support UK NHSX Market With Remote Care Monitoring Service – Named Supplier For Crown Commercial Services (CCS)

Digital Health Company HealthBeacon is excited to announce they have been appointed as a supplier on the Crown Commercial Service (CCS)’s , SPARK Dynamic Purchasing System (DPS). The appointment, granted after a competitive process, provides HealthBeacon with direct access into the UK healthcare market supporting patients that manage injectable medications across therapeutic areas. The significant supply appointment will springboard the innovative med tech firms expansion across the NHS UK health network.

HealthBeacon responded to the NHSX’s further competition run via Crown Commercial Service’s (CCS) Spark Dynamic Purchasing System for companies to up-scale remote monitoring across the health service to support COVID-19 patients and management of people with long-term conditions for the next phases of the pandemic. HealthBeacon applied to the Spark DPS to provide Remote Monitoring Technology Platforms and includes both vital signs monitoring and out-patient support.

Improving Health Outcomes

The HealthBeacon Injection Care Management System™ offers digitally enabled remote care monitoring and support service for patients managing self-injectable medications across all therapeutic areas.

The self-injectable market for home administered medications is estimated to be over €60B globally.  However, one of the major challenges for people self-injecting medication is adhering to treatment schedules, resulting in both a significant loss to patient health and a rapidly escalating financial burden on state health care systems.

Evidence shows that, on average patients comply with their chronic medicine schedules only 50-60% of the time.  80% – 90% compliance can be achieved when medicines are connected with adherence support solutions – which is where HealthBeacon steps in.

HealthBeacon products are designed with patient empowerment at top priority which has led to 96% of patients accepting HealthBeacon products as part of their treatment.

Growth Opportunity

The self-injectable market for home administered medications is very large – consuming almost 16% of total annual drug spend. It is also the fastest growing component of the medicines market.

The CCS supports the public sector to achieve maximum commercial value when procuring common goods and services. In 2018/19, CCS helped the public sector to achieve commercial benefits worth £945m – supporting world-class public services that offer best value for taxpayers

In response to the rapidly changing COVID-19 landscape, HealthBeacon Injection Care Management System ™ enhanced its offering to help patients stay on track with critical medication, safely dispose used injection devices including a sustainable waste management service (HB Green Labs) limit unnecessary visits to the hospital and give the patient´s clinical team an excellent remote care monitoring opportunity relevant to each therapeutic area.

Speaking about this exciting development for HealthBeacon Malin Johansson, HealthBeacon, Vice President Europe, commented; “We are delighted to become a CCS supplier and welcome the opportunity to work with new providers and provide remote monitoring care support throughout the UK.  The spike in demand globally for remote support services from healthcare providers in response to Covid-19 pandemic highlights the importance of empowering and supporting patients remotely”.

Malin added; “We saw an opportunity to enhance our existing platform during the pandemic as a reliable and effective alternative for suppliers and patients requiring remote care during lockdown and ‘at risk’ phases as a result of the ever challenging current health landscape.   This is a significant opportunity for HealthBeacon as it provides a direct route into the UK Health market.  We looking forward to engaging with potential partners throughout the UK interested in working together

Jim Joyce, CEO and Co-Founder HealthBeacon, added “Patient empowerment is our top priority at HealthBeacon.  Our system has evolved to provide complete 360 care for patients on injectable medications.  We automated the process for adhering to medications so there is no longer the need to remember complicated schedules.  This enables the user with greater equanimity and increases health outcomes for patients and providers alike.”  

HealthBeacon embraces end to end sustainability and earlier this year launched Green Labs – its sustainable waste management service which reuses sharps bins and recycles injection waste.  Its world leading proprietary technology and new capabilities were designed to address the huge burden of healthcare waste globally, from its Irish hub with its online community.

Jim Joyce added; “Sustainable digital health technology has a huge role to play in future health empowering patients and improving health outcomes. HealthBeacon are committed to ensuring vulnerable patients adhere to medication and continue to access critical medications, safely.

 

17 Jul

HEALTHBEACON TO SPONSOR AT THE MAGIC FOUNDATION’S 26TH ANNUAL CONVENTION.

[Boston, MA., Jul. 17 2020] – HealthBeacon, a medication adherence technology company that develops smart tools for managing medication, is proud to sponsor the MAGIC Foundation’s 26th Annual Virtual Convention on July 17th – July 18th, 2020.

The MAGIC Foundation is the global leader in endocrine health, advocacy, education and support for human growth disorders. HealthBeacon is proud to sponsor the MAGIC Foundation Convention for the 3rd consecutive year. Laura Hamilton, CEO of North America will be showcasing HealthBeacon’s Injection Care Management System.  She notes, “The MAGIC Foundation Convention provides a powerful opportunity to connect with patients on injectable Growth Hormone Therapy, as well as Pediatric Endocrinologists. This year we are pleased to share research regarding medication adherence from a Growth Hormone patient study and to capture new insights from patients through our virtual booth. We are excited to offer enrollment to a complimentary HealthBeacon program, exclusively available to attendees of this year’s MAGIC Foundation Convention.”

In years past, HealthBeacon has had the opportunity to meet endearing patients, along with their families and hear their experiences in managing their daily medication routine.Although this year’s event is virtual, we look forward to hearing patient stories, connecting with Clinicians and continuing to support the great work of the MAGIC Foundation.

About HealthBeacon

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication. HealthBeacon’s FDA-cleared “smart sharps bin” tracks patient injection history, provides personalized interactive reminders and safely stores used injections. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy.  HealthBeacon’s integrated model connects a patient’s routine and the prescribing clinician’s workflow.  This technology has been adopted across 14 countries with >400,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%.

For more information, visit: www.healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter.

About MAGIC Foundation
The MAGIC Foundation was incorporated in the state of Illinois and received 501(C)3 non-profit status October 29, 1989. Since its inception, the Foundation has grown to include support services for adults who were also impacted by these disorders.

15 Jul

Medication Adherence to Growth Hormone Therapy (GHT) from Members of the MAGIC Foundation

Sean Glynn, M.S., is the Director of Health Economics & Outcomes Research for HealthBeacon in North America

 

1-in-4 Patients struggle to stay on track with medication

 

Staying on track with medication for chronic conditions has a myriad of challenges.  In 2019, The MAGIC Foundation, supported by HealthBeacon, heard from 508 member families on the extent to which they are able to stay on track and what gets in their way.

This white paper includes a summary of the study and findings, if you would like to learn more, please contact laura.hamilton@healthbeacon.com.

There were 508 respondents to the survey.  Females represented 42% of all respondents and almost 86% of those who completed the survey were the guardian or caregiver of a pediatric patient. Other demographics can be found below.

 

One-in-four patients were classified as sub-optimally adherent.  Female patients were more likely to be sub-optimally adherent than their male counterparts.  There was a significant increase in the number of sub-optimal patients after the first year of treatment from 13% to 21%.  Patients who start on a 6 dose per week schedule are significantly more likely to be sub-optimally adherent in the later years of their therapy compared to those on a 7 dose per week schedule.

When asked why patients were missing doses, the most frequent answer was “We were busy and forgot” at 36%.  Only 25% of respondents reported using some type of tool or system to stay on track and approximately 50% said they would benefit from reminder support.  Interestingly, those who said they did not need this type of support were more likely to be sub-optimally adherent.

“Even the best of families can struggle with adhering to their therapy. Frankly, I was a bit shocked by the self-reported adherence numbers from the MAGIC survey.” 

Aristides Maniatis, MD

Rocky Mountain Pediatric Endocrinology

Considering that self-reported medication adherence tends to be over-estimated and that The MAGIC Foundation member families represent a cohort with means and access to benefit from the foundation’s services, GHT medication adherence for the population at large is likely less favorable than what is reported above.  GHT patients would benefit from further support to optimize a short treatment window.  Tools and systems that will help them stay on track can play an important role in the treatment journey.

 

We would like to thank The MAGIC Foundation for their support of this research.  We would further like to thank Dr. Mitchell Geffner, Children’s Hospital Los Angeles, and Dr. Aristides Maniatis, Rocky Mountain Pediatric Endocrinology, for their input, guidance and assistance.

 

Download Whitepaper:

Medication Adherence to Growth Hormone Therapy (GHT) from Members of the MAGIC Foundation

About HealthBeacon

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication. HealthBeacon’s FDA-cleared “smart sharps bin” tracks patient injection history, provides personalized interactive reminders and safely stores used injections. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy.  HealthBeacon’s integrated model connects a patient’s routine and the prescribing clinician’s workflow.  This technology has been adopted across 14 countries with >400,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%.

For more information, visit: www.healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter.

 

About MAGIC Foundation

The MAGIC Foundation was incorporated in the state of Illinois and received 501(C)3 non-profit status October 29, 1989. Since its inception the Foundation has grown to include support services for adults who were also impacted by these disorders.

05 May

HealthBeacon Launches COVID-19 Services for ‘At Risk’ Patients

HEALTHBEACON LAUNCHES COVID-19 SERVICES FOR ‘AT RISK’ PATIENTS

Irish Digital Health Company Adapts Services Helping Patients on Injection Therapy Access Critical Medications

Now Available to Laya Healthcare Members

[Dublin, Ireland., May 5, 2020] – HealthBeacon a medication adherence technology company, has launched a new Covid-19 support offering for patients on injectable therapies which is now available to laya healthcare’s 600,000 members.

HealthBeacon has developed the world’s first Injection Care Management System for patients that self-administer injectable medication in their homes. HealthBeacon eases the burden of managing patients’ injectable medications from home through their Smart Sharps Bin Technology.

During this time of crisis, it is critical that people with chronic conditions continue to take their medications as prescribed by their healthcare professionals while maintaining social distancing and avoiding unnecessary exposures. For this reason, the HealthBeacon Injection Care Management System is being expanded to offer additional services to further support individuals in their homes.

The enhanced HealthBeacon offering, now available to laya healthcare members includesvirtual care support, coordination of medication delivery, medical waste collection, and home monitoring with the HealthBeacon Smart Sharps Bin. This service will reduce the number of visits to the pharmacy and hospitals for those ‘at-risk’ while ensuring patients will continue to take critical medications.

Jim Joyce, CEO HealthBeacon said; “We are delighted that laya healthcare has agreed to cover this service for their members during these unprecedented times, it is critical to adapt and innovate to ensure continued support to patients.  Digital health technology has a huge role to play during COVID-19 and we want to ensure vulnerable patients are able to access critical medications.”

John McCall, Director of Claims and Provider Relations at laya healthcare welcomed the innovative support provided by HealthBeacon to its members “Members who need to regularly inject themselves at home will welcome this new service we’re now offering as part of our enhanced healthcare benefits available at no additional cost until the end of June 2020. It’s just another way we’re looking after our members, always.

ABOUT HEALTHBEACON

HealthBeacon is a medication adherence technology company which develops smart tools for managing medication at home. HealthBeacon’s FDA cleared smart sharps bin tracks patient injection history, provides personalized interactive reminders and safely stores used injectables. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy.  The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow.  This technology has been adopted across thirteen countries with >300,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%. For more information, visit: www.healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter.

Media Contact:

Mary Principe | comms@healthbeacon.com

27 Mar

A Message from our CEO, Jim Joyce

COVID-19 Response

Jim Joyce
CEO and Co-Founder, HealthBeacon

HealthBeacon appreciates and understands that our healthcare systems and healthcare workers feel the weight of the world on their shoulders.

At this time, HealthBeacon is working with governments and insurers to immediately add new capabilities within our Injection Care Management System. Please take a moment to listen to HealthBeacon CEO Jim Joyce outline our response to the COVID-19 situation including accelerating plans to launch HealthBeacon’s Companion App with in-home care capabilities for the at-risk population that we support each day.

Healthbeacon’s Companion App will enable the following capabilities at our at-risk population:

  • 24/7 Support
  • Virtual Injection Training
  • On-Demand Medication Supply Management to ensure that patients have adequate medication in their home and can reduce interaction with Hospitals and Pharmacy while the risk of infection is high (*available in select markets) 

 

The work that our global colleagues in the Pharmaceutical and HealthCare sectors are doing to improve care, treat and support vulnerable remotely managed patients have never been more important so we will not relent in our mission.

Wishing you all good health.

 

ABOUT

26 Feb

Maximising Patient Adoption with Lara Kelly

Q&A

with Lara Kelly,
Head of Data Analytics, HealthBeacon

In January, we launched our adoption series, assessing the multiple considerations required to create useful technologies within the complex landscape of healthcare. This was followed by HealthBeacon CEO, Jim Joyce, reflecting on the importance of keeping technology human, making reference to the significance of simple acts, such as the inclusion of a smile. 

NextDr. Zara Kinsella Fullerton does a Q&A session with Lara Kelly, head of Data Analytics at HealthBeacon tlearn about the benefit of a data driven approach, when it comes to maximising patient adoption. 

TELL ME ABOUT YOURSELF

I am the head of Data Analytics at HealthBeacon. My background is in Biomedical Engineering which I studied at Trinity College in Dublin. 

For a very long time, I thought that I wanted to be a doctor. However, as time passed, I became passionate about using the data captured from digital tools to support and improve patient care.  

like to think of the HealthBeacon as the key that unlocks the data, which enables us to make really smart decisions!  

FROM A DATA PERSPECTIVE, HOW WOULD YOU DEFINE ADOPTION?

Adoption is something that is often referenced, but the meaning can be unclear, particularly when it comes to digital health technologies. Defining adoption is a topic that has certainly led to much debate amongst the team – taking a purely data driven approach we would classify a patient as a “HealthBeacon adopter” if they consent to the service, their HealthBeacon is communicating with us (we are a connected device after all!) and the patient has continued to use the device for a period of time. But we are dealing with the human psyche after all, so it is not as straightforward as this! 

The big question we grapple with, is how long does the patient need to use the HealthBeacon for us to classify them as an adopter? It is a matter of individual patient characteristics. According to a study published in the European Journal of Social Psychology, it takes 18 – 254 days for a person to form a new habit – and on average, 66 days for a new behaviour to become automatic. ¹

As a result of this broad time range, there is no hard and fast rule on the period of time required before we can classify a patient as being a true adopter. At HealthBeacon, we use a threshold of 90 days. Some might argue we are being hard on ourselves, however, as maximising patient adoption is one of our core values, we would rather under-estimate our true adoption rates and consistently strive to improve them than reach a level of complacency. 

HAS HEALTHBEACON PERFORMED ANY RESEARCH RELATING TO ADOPTION?

We completed a study to assess our adoption rates and presented our findings at the Connected Health Conference in Boston, MA in October 2019.

The key finding from an analysis of 756 devices collected over a 24-month period, was that 77% of devices were adopted. We were delighted to find that this exceeds many of the adoption rates seen in studies of consumer self-tracking technologies.² 

If you would like to find out more information about HealthBeacon’s research relating to patient adoption, please email comms@healthbeacon.com to receive a copy of the poster presented at the Connected Health Conference.

IN YOUR OPINION, WHAT IMPACTS ADOPTION OF HEALTH TECHNOLOGIES?

There are many factors that can impact adoption. Patient and disease related factors play a big part as well as device usability – how easy it is for someone to incorporate that technology in their daily lives.  

 As we now have 10,000 devices and patient experiences to learn from, we have formed a theory on why the HealthBeacon is so widely adopted or “USED”  

USER NEED:  Patients have to put their sharps somewhere and often are legally obliged to do so

SMART INTERVENTIONS: The system only intervenes when required

EASY: All the patient has to do is plug it in

DISCREET DESIGN: Replacing the conventional sharps bin

Designing patient-centric tools while capturing actionable data can often be difficult to achieve simultaneously. Over the last year we have spent a lot of time reviewing and introducing improvements to the patient experience – much of this is in the form of additional and smoother patient touch-points – this means we are collecting a lot more data but we must continuously ensure that the data we capture is actionable 

To help us achieve the perfect balance, we opened HB Labs which facilitates extensive collaboration between the data and product teams. Once devices have been tested in the user lab and are released for patient use, the data team constantly monitors and identify new behaviours and insights. These are fed back to the product team to ensure all learnings are incorporated in the design of future products.  

Additionally, any findings from our research relating to adoption is also integrated into this process. 

WHAT'S NEXT FOR THE HEALTHBEACON DATA TEAM?

The data will keep flowing and we will keep learning and improving!  

One project that I am particularly excited about, is the use of machine learning to predict if a patient is likely to take their next dose on-time. 

Today, the HealthBeacon enables us to identify which patients forget to take their medication and intervene accordingly – this work will enable us to identify them and intervene before they have even forgotten to take their medicationThis will be our smartest intervention yet but more importantly it should improve the patient experience which ultimately is the key to successful adoption!  

WHEN YOU AREN'T IN THE HEALTHBEACON DATA LABS, WHERE MIGHT WE FIND YOU?

When I am not at work, my three favorite things to do are exercising, cooking and travelling – in no particular orderYou may find it hard to believe, but I spent over a year researching the potential of a method to inject encapsulated stem cells into the intervertebral disc, as a technique for minimally invasive repair. I would have to feed the cells every 5 days – even though I found this fascinating, my family (who are the farthest from scientifically minded that you can think of) used to find this bizarre   

ABOUT

This article was written By Lara Kelly and Dr. Zara Fullerton Kinsella at HealthBeacon. 

Dr. Zara Fullerton Kinsella, has a degree in Business and Economics from Trinity College Dublin and a Medical Degree from University College Cork. She is the Medical Science Liaison at HealthBeacon.

Lara Kelly, has a degree in Mechanical Engineering and a Masters in Biomedical Engineering from Trinity College Dublin. She is Head of Data Analytics at HealthBeacon. 

  1. Lally. P., 2009, How are habits formed: Modelling habit formation in the real world, European Journal of Social Psychology 
  2. Kooiman, T., and Schans, C.,2018, The use of self-tracking technology for health. 1st ed.: Rijksuniversiteit Groningen, p.12. 
07 Feb

Achieving Patient Adoption: Should Digital Health Tools Smile?

By Jim Joyce, CEO & Co-Founder of HealthBeacon and Dr. Zara Fullerton Kinsella, Medical Science Liaison for HealthBeacon

This is the second series reflecting on the adoption of healthcare technologies. In this piece, Jim Joyce asks the question – “Should Digital Health Tools Smile?”

“I gave them a smile, they gave me one back, so I gave them another”– Unknown

Should Digital Health tools smile at you?  I’m called into a packaging meeting for final sign off on the box that will deliver HealthBeacon Smart Devices to patients across the USA, in this case, it is for a partnership with one of the biggest healthcare providers in the USA. Our brilliant tech and design team have spent considerable time brainstorming the box and answering questions: Will a patient know what to do when they receive it? Is it easy to open? Easy to take the device out? Will it be intuitive to plug-in and set up? These are all critical questions that we believe we have a good handle on, but my team has one final point of debate. Should we put a smile on the inside flap of the box? For me, the answer is clear, but we paused for a moment to consider the smile. As a company, we operate globally across 20 countries and even within America the meaning of a smile may be interpreted differently across different states, context and demographics.

Our history with the question, “Should it smile?”, goes back to our earliest prototype, the way our technology works is that each time a patient uses the HealthBeacon device by disposing of their used injection into the HealthBeacon the device smiles at you through the LCD screen.

We initially included the smile because the first versions of our device needed up to 60 seconds to send the time-stamped image of your medication to our servers through a mobile network. During the transition time, many people thought the device might not be working so we introduced the smile during the transmission with the words “Well Done”. The feedback from our patients was great,  “I love how it smiles at me” and “I don’t want to disappoint my HealthBeacon, because I know it wants me to feel better”. The small smile on the screen introduced a bit of humanity to a fairly technical activity of injecting yourself subcutaneously and then disposing of your used injection into our device. Now our devices are communicating immediately, but we have kept the smile.

I was recently at a lecture hosted by the Euronext Stock Exchange, where Dermot Crowley, Deputy CEO of the hotel group, Dalata, paused for a moment to talk about the importance of guests being greeted by smiling staff at each of their hotels. He stated that the first thing he notices is whether the staff smile. It is a critical moment when a guest walks into our hotels, they may be tired from travel or disorientated and being welcomed with a smile can make all the difference.

So why the debate on whether to include a smile? What’s the counterpoint? You’re not taking something seriously and healthcare is serious. You’re not being authentic in your smile? Once a European pharmaceutical executive told me I was being “too American” and the smile might be considered condescending, “it won’t work here, we just don’t smile that much.”

I asked Dr. Zara, our Medical Science Liasion to comment on the science behind the smile:

“Smiling is something we are all familiar with; many of us smile more than 20 times a day and children often smile as much as 400 times in a 24 hour period 1 but what about the science behind these smiles? 

There has been a vast amount of research focusing on the smile, dating as far back as 1862, when French anatomist, Guillaume Duchenne described the results of his work stimulating facial muscles with electric currents and emphasised the significance of eye muscle contraction when smiling. Today, this Duchenne smile, is more commonly referred to as ‘Smizing’.3

The ability of facial expressions to impact our mood was first described by William James and Charles Darwin 4,5 and has been the subject of much research.6 Smiling has been associated with the release of neurotransmitters such as serotonin and dopamine with associated health benefits.

The long-term benefits of smiling are also fascinating.2 Smiling has been linked with increased lifespan in professional athletes 8 and higher levels of marital satisfaction and wellbeing.9 Furthermore, research by Hewlett Packard and Dr. Lewis found that a single smile can result in the same level of brain stimulation as consuming 2,000 bars of chocolate, or obtaining a significant amount of cash.10 

At HealthBeacon we believe we can back up the smiles, it’s part of the culture and it makes sense that we would embed our culture in our technology, communications and packaging.  We want our technology to remove pain, burden, isolation and reduce complexity. We understand that we are a small piece of a big puzzle to help our customers live happier and healthier lives. In a recent in-person survey at HealthBeacon, 90% of our staff spontaneously responded to a smile with a smile. Since smiling is clinically proven to be contagious we are hoping we will infect the last 10% of the staff.

Are we serious enough? The evidence suggests that smiling in the workplace has a direct correlation to productivity and competence, but it does have its limitation and there are times when the absence of a smile is an important message. In our new companion app, we are working on a module that will have people earn their smile, it’s early days so we don’t yet know the impact, but we will keep you posted.

So for the inside flap of the box, it’s a “Yes”. We believe the evidence is clear and it will bring a bit of humanity to the box. Sometimes it just makes sense to not overthink things and smile.

_________________

ABOUT

This article was written by Jim Joyce and Dr. Zara Fullerton Kinsella, HealthBeacon. Zara has a keen interest in digital health, particularly in the potential for disruptive technologies to enable individualised models of care, within the context of limited healthcare resources.

Jim Joyce has an MBA from University College of Dublin and BA in Economics from Fordham University. He is the CEO and Co-Founder of HealthBeacon, A Dublin Ireland based medical adherence technology company.

Jim Joyce, CEO of HealthBeacon

Dr. Zara Fullerton Kinsella has a degree in Business and Economics from Trinity College Dublin and a Medical Degree from University College Cork. She is the Medical Science Liaison at HealthBeacon.

Dr. Zara Fullerton Kinsella

MEDIA CONTACT

If you have any thoughts about this article, please get in touch at comms@healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter. We would love to hear from you!

 

[1] Goodman, R., 2011, The Untapped Power of Smiling, Forbes. https://www.forbes.com/sites/ericsavitz/2011/03/22/the-untapped-power-of-smiling/#1284fb7d7a67
[2] Jaffe, E., 2010, The Psychological Study of Smiling, https://www.psychologicalscience.org/observer/the-psychological-study-of-smiling
[3] Duchenne G.B., 1990, The mechanism of human facial expression, translation R.A. Cuthbertson, Cambridge University Press
[4] Darwin, C., 1872, The Expression of the Emotions in Man and Animals, London: J. Murray
[5] Goleman, D., 1989, A Feel Good Theory: A Smile Affects Mood https://www.nytimes.com/1989/07/18/science/a-feel-good-theory-a-smile-affects-mood.html
[6] Skibba, R., 2016, Psychologist argue about whether smiling makes cartoons funnier, Nature Journal of Science, https://www.nature.com/news/psychologists-argue-about-whether-smiling-makes-cartoons-funnier-1.20929
[7] Riggio, R., 2010, There’s Magic in Your Smile, https://www.psychologytoday.com/us/blog/cutting-edge-leadership/201206/there-s-magic-in-your-smile
[8] Abel E. and Kruger M.,2010, Smile Intensity in Photographs Predict Longevity, Psychological Science, 21, 542–544
[9] Harker L. and Keltner D. 2001, Expressions of Positive Emotion in Women’s College Yearbook Pictures and Their Relationship to Personality and Life Outcomes Across Adulthood. Journal of Personality and Social Psychology, 80, 112, 124
[10] Rickman, C., 2019, The Happiness Bible: The Definitive Guide to Sustainable Wellbeing